![CAS No 143824-78-6 ((2S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-[1-[ (2-METHYLPROPAN-2-YL)Oxycarbonyl]Indol-3-Yl]Propanoic Acid Pharmaceutical Intermediates](https://ecdn6.globalso.com/upload/p/2209/image_other/2025-11/143824-78-6-structural-formula_thumbW360.jpg)
CAS No 95635-56-6 RANOLAZINE DIHYDROCLORIDE Pharmaceutical Intermediates
Overview
Ranolazine dihydrochloride is a new antianginal drug mainly used to treat chronic stable angina. It works by improving blood flow to the heart muscle, thereby reducing the frequency and severity of angina attacks.
Unlike traditional antianginal therapies, ranolazine dihydrochloride does not significantly affect heart rate or blood pressure, making it a unique and effective option for patients who have responded poorly to other therapies. Its mechanism of action involves inhibition of late sodium currents, which helps reduce myocardial oxygen demand and enhances overall cardiac function.
Physical and chemical properties
- Appearance:off-white solid
- Solubility: Soluble in water and organic solvents such as methanol and dimethyl sulfoxide (DMSO), which is beneficial for formulation into various dosage forms.
- STABILITY: Ranolazine dihydrochloride exhibits good stability under recommended storage conditions, ensuring longer shelf life and reliability in therapeutic applications.
These properties make ranolazine dihydrochloride suitable for the formulation of a variety of pharmaceutical products, including tablets and extended-release formulations.
There are many advantages to using ranolazine dihydrochloride in pharmaceutical formulations:
- UNIQUE MECHANISM OF ACTION: Ranolazine dihydrochloride targets late sodium currents, thereby providing a unique treatment approach that makes it effective in patients with chronic stable angina who may not respond to conventional treatments.
- MINIMAL SIDE EFFECTS: Unlike many other antianginal drugs, ranolazine dihydrochloride does not significantly affect heart rate or blood pressure, making it a safer option for a wider range of patients.
- Improve quality of life: Clinical studies have shown that ranolazine dihydrochloride can enhance exercise tolerance and reduce the frequency of angina attacks, thereby improving patients' quality of life.
- Regulatory Compliance: Our Ranolazine Dihydrochloride is manufactured in compliance with international pharmaceutical standards ensuring compliance with the stringent requirements set by health authorities.
As a production and trading integrated factory, we are committed to providing customers with high quality ranolazine dihydrochloride. Our dedication to quality is reflected in our advanced manufacturing processes and strict quality control measures.
- Expertise: Our team of professionals is dedicated to research and development, ensuring we remain at the forefront of pharmaceutical innovation.
- Customer-centric approach: We prioritize our clients' needs, providing customized solutions and responsive customer service to support their specific needs.
- Sustainability: We are committed to using sustainable practices in our manufacturing processes to ensure we maintain product quality while minimizing our impact on the environment.
In conclusion, ranolazine dihydrochloride is an important pharmaceutical ingredient that may provide multiple benefits in the treatment of chronic stable angina. With our combined production capabilities, high quality standards and commitment to customer satisfaction, we are your ideal partner in the pharmaceutical industry. Choose our ranolazine dihydrochloride for your formula and experience the difference in quality and efficacy.
For inquiries or to place an order, please contact us today!